SAEMF/Medical Toxicology Foundation (MTF) Toxicology Research Grant
Application Deadline: August 1, 2021
This document provides an overview of the MTF-SAEMF Toxicology Research Grant. For complete instructions on applying, please see the Detailed Instructions. For submission instructions and policies, visit How To Apply. For answers to other common questions, visit our Grants FAQ.
All application components, including letters of support, must be submitted through the SAEM Foundation Grant Portal. All applications must be received by 5 pm (Central time) on their due date. No additional material (e.g. updates, publications, corrections, etc.) will be accepted after the application deadline.
Applicants must use the most current version of the National Institutes of Health (NIH) PHS 398 forms which can be downloaded at: http://grants1.nih.gov/grants/funding/phs398/phs398.html#forms. If there are questions regarding formatting, formatting which conforms to NIH guidelines will always be accepted.
The latest NIH biosketch format should be used for the applicant, mentor(s), and other key personnel. This includes a section for a personal statement. See biosketch instructions for further information.
Font type and size for the application should be Arial 11 point, including literature cited. Single line spacing is acceptable. Figures, charts, tables, and legends or captions may be in smaller size font but must be clear and legible.
Blank/plain paper can be used as needed in lieu of continuation pages when no form is specified to be used. The margins must be no less than the following dimensions: top: 0.8, bottom: 0.5, left: 0.5, right: 0.5.
Submission must be no longer than 7 pages in length (excluding references). All proposals must include specific aims, background/significance, preliminary work (if applicable), and approach.
A minimum of two letters of reference are requested, with one from the department chair or equivalent and the other from the mentor, whose letter should include a mentorship plan and testament to support the applicant for the duration of the award. A proposed budget and budget justification for how funds will be allocated during the one-year period are also required.
PURPOSE OF THE AWARD
The mission of the grant is to provide support for research proposals that advance the science of medical toxicology in emergency medicine. The goals are to foster collaboration between members of ACMT and SAEM and to advance the science of medical toxicology as it relates to all aspects of emergency medicine. Proposals that intend to collect data necessary to pursue larger projects (pilot projects) are of particular interest. The research proposals can address one or more of the following areas and topics:
- Medical toxicology practice
- Medical toxicology education (medical students, emergency medicine residents, medical toxicology residents and emergency physicians)
- Acute or chronic toxicity from pharmaceuticals and chemicals
- Envenomations and natural toxins
- Opioid-use disorders and addiction medicine
- Chemical or radiological emergency preparedness
- Global medical toxicology
The applicant must:
- Be a member in good standing of SAEM at application deadline and during the entire award period;
- Be a physician holding an applicable terminal clinical degree (e.g., MD, DO);
- Be an emergency medicine resident, or a medical toxicology fellow, or faculty member in good standing in an Accreditation Council on Graduate Medical Education (ACGME)-approved emergency medicine residency program are also eligible for the award;
- Not have received the MTF-SAEMF Toxicology Research Grant previously.
Greater consideration for receipt of the award will be given to applicants who:
- Have demonstrated promise and success in similar projects relevant to medical toxicology or emergency medicine. Evidence of this promise may include previous participation in research activities related to these fields, peer-reviewed publications and presentations, presentations of scholarly activity at scientific meetings, and local, regional, national and international activities focused on research and education.
- Demonstrate evidence of involvement in MTF or SAEM activities and functions. Considerations in this regard include participation in ACMT and/or SAEM activities and functions (e.g., presentations and committee membership). Applicants will be scored according to their expressed and demonstrated commitment to ACMT and SAEM.
The Applicant's Host Institution
The host institution must:
- Provide adequate administrative and clerical support to the applicant and project, including but not limited to: office space, administrative support, and information systems;
- Demonstrate a track record of involvement and commitment to medical toxicology and emergency medicine research.
- Demonstrate the availability of faculty, resident and /or medical student teaching opportunities relevant to the project and applicant’s needs for the project;
THE FINANCIAL AWARD
The MTF-SAEM Foundation Toxicology Research Grant will provide up to $10,000 for an applicant’s project, contingent on the availability of funds. The SAEM Foundation may discontinue, postpone, or change grant funding based on the amount of funds available. The number and monetary amount of awards granted will depend on the quality of applications and status of the funds. Funds from the grant may be used for direct costs related to the project. A maximum of $1000 may be used for travel to conferences to present research findings.
Funds from the grant may not be used for faculty salary support. Statistical support costs are allowable under this grant. Indirect costs (i.e., facilities and administrative costs) are not supported by this grant. No additional costs are supported by the SAEM Foundation; any other costs are the responsibility of the applicant’s host institution. Any residual funds will be returned to SAEM Foundation at the end of the award period.
Costs included in the budget may not exceed $10,000 per year. However, in addition to the funds from this grant, the budget justification should reflect all pending and active sources of funding relevant to the project. The submission of a detailed budget and budget justification with both awarded funds and additional funds available to support the project from all sources are required as part of the application.
Failure to meet the award guidelines or inability of the awardee to complete the term of the award shall result in the return of remaining funds to SAEM Foundation.
For projects requiring the host institution’s Institutional Review Board (IRB) or equivalent approval, funds will not be dispersed until IRB approval is obtained. Award extensions may be made at the discretion of the Grants Committee on a case-by-case basis.
DURATION OF THE AWARD
The award is for one year (grant period July 1, 2022 - June 30, 2023).
A progress report is due on December 1 during the grant period. The final project and financial report are due June 30th at the end of the grant period. The progress report template is available at Post Award.
At the end of the grant award year (June 30th), the awardee is expected to provide the SAEM Foundation with a final report outlining the work completed during the research project. Successful project completion will be demonstrated by at least one of the following: (1) a research abstract submitted to the ACMT, SAEM or other national meeting relevant to the project topic, and/or (2) a manuscript submitted to a peer-reviewed publication relevant to the project topic. The awardee also is expected to attend the ACMT or the SAEM Annual Meeting during their award year, preferably presenting a topic from their research.
GRANT REVIEW PROCESS
The SAEM Foundation Grants Committee is responsible for reviewing grant applications for this award and will make recommendations to the SAEM Foundation and MTF Board of Trustees. The committee uses a scoring system to judge and compare applications according to the review criteria listed below. The committee seeks to recommend applications with a high likelihood of completing an innovative, high impact project. Applications will be evaluated on several parameters:
- the scientific content of the research project, including:
- a thorough background literature review
- a clearly expressed research hypothesis
- a detailed description of study methodology including anticipated timelines
- sample size calculations (where appropriate)
- statistical analyses o anticipated challenges and mitigation strategies
- knowledge translation efforts
- budget justification
- the anticipated significance, novelty and feasibility of the project
- the qualifications of the supervisor and other team members
- the role of the applicant in the initiation, development, conduct, and reporting of the project
- the anticipated educational experience for any involved trainees
- any other support (financial or in-kind) relevant to the conduct of the research
Please contact email@example.com with any questions.
Updated March 1, 2021
POLICIES GOVERNING THE USE OF HUMANS AND ANIMALS
If human or animal experimentation is to be performed during the period of the award, the department and institution to be used as the training site must affirm that: (1) investigations involving human subjects proposed and subsequently carried out in the application have been endorsed and approved by the IRB, or other clearly designated appropriate body, at the study site; (2) any research involving human subjects will conform ethically with the guidelines prescribed by the NIH; and (3) research involving animals will conform with the current "Guide for the Care and Use of Laboratory Animals", NIH publication, of the Department of Health and Human Services/United States Public Health Service (DHHS/USPHS), and has been approved by the Animal Care and Use Committee at the study site
INVESTIGATORY FINANCIAL DISCLOSURE POLICY/OBJECTIVITY IN RESEARCH
Applicants and institutions are required by SAEMF to comply with the USPHS regulations, Final Rule, 42 CFR Part 50, Subpart F: Responsibility of Applicants for Promoting Objectivity in Research. The applicant’s and mentor’s institution or host institution official’s signature on the signature page of the application indicates compliance that an institutional administrative process is in effect to identify and resolve conflicting financial interests of the type described in Subpart 50.604(a) with respect to all projects for which funding is sought from SAEMF.
PATENT, INTELLECTUAL PROPERTY, AND TECHNOLOGY TRANSFER POLICY
All inventions discovered or arising out of research supported in whole or in part by SAEMF, which may be used in emergency medicine research, teaching, or practice, shall be reported within one (1) year to SAEMF. "Invention" is any discovery, material, method, process, product, program, software or app (mobile, application software, web application, etc) of use, whether or not patented or patentable or copyrighted or copyrightable, that has application of value such that its use, licensing, lease, or sale can generate revenue.
If the institution receiving or disbursing SAEMF funds that supported the invention has an established and applicable patent, intellectual property, or technology transfer policy/procedure for administering inventions, SAEMF will defer to that policy. If the institution has no established and applicable patent, intellectual property, or technology transfer policy/procedure for administering inventions, SAEMF shall have the right to determine the disposition of invention rights. In such cases, SAEMF may:
- Decide that patent and copyright should be or not be filed;
- Release the invention to the inventor(s) or inventor's designee;
- Submit the invention to a qualified organization for administration and licensing;
- Determine by negotiation the fair share of royalty income to be paid to the inventor(s);
- License or make other arrangements for the application and use of the invention on an exclusive or non-exclusive, royalty, or royalty-free basis.